About this item:

241 Views | 291 Downloads

Author Notes:

Joseph M. Bliss, MD, PhD, Department of Pediatrics, Women & Infants Hospital of Rhode Island, 101 Dudley Street, Providence, RI 02905, Email: jbliss@wihri.org.

We are indebted to our medical and nursing colleagues and the infants and their parents who agreed to take part in this study.

The funding agencies provided overall oversight for study conduct, but all data analyses and interpretation were independent of the funding agencies.

Data collected at participating sites of the NICHD Neonatal Research Network (NRN) were transmitted to RTI International, the data coordinating center (DCC) for the network, which stored, managed and analyzed the data for this study.

A list of members of the Candida Subcommittee of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network is available at www.jpeds.com (Appendix).

A portion of these data were presented in abstract form at the Pediatric Academic Societies’ Annual Meeting, May 2010, Vancouver, BC, Canada.

Subjects:

Research Funding:

Supported by the National Institutes of Health and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD (grant).

D.B. received support from the Thrasher Research Fund and NICHD (HD44799).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Pediatrics
  • HUMAN-IMMUNODEFICIENCY-VIRUS
  • CELL-SURFACE HYDROPHOBICITY
  • INVASIVE FUNGAL-INFECTION
  • BIRTH-WEIGHT INFANTS
  • RISK-FACTORS
  • GENE-EXPRESSION
  • ALBICANS
  • PARAPSILOSIS
  • EPIDEMIOLOGY
  • ADHESION

Candida Virulence Properties and Adverse Clinical Outcomes in Neonatal Candidiasis

Tools:

Journal Title:

Journal of Pediatrics

Volume:

Volume 161, Number 3

Publisher:

, Pages 441-+

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Objective: To determine whether premature infants with invasive Candida infection caused by strains with increased virulence properties have worse clinical outcomes than those infected with less virulent strains. Study design: Clinical isolates were studied from 2 populations of premature infants, those colonized with Candida spp (commensal; n = 27) and those with invasive candidiasis (n = 81). Individual isolates of C albicans and C parapsilosis were tested for virulence in 3 assays: phenotypic switching, adhesion, and cytotoxicity. Invasive isolates were considered to have enhanced virulence if detected at a level >1 SD above the mean for the commensal isolates in at least one assay. Outcomes of patients with invasive isolates with enhanced virulence were compared with those with invasive isolates lacking enhanced virulence characteristics. Results: Enhanced virulence was detected in 61% of invasive isolates of C albicans and 42% of invasive isolates of C parapsilosis. All C albicans cerebrospinal fluid isolates (n = 6) and 90% of urine isolates (n = 10) had enhanced virulence, compared with 48% of blood isolates (n = 40). Infants with more virulent isolates were younger at the time of positive culture and had higher serum creatinine levels. Conclusion: Individual isolates of Candida species vary in their virulence properties. Strains with higher virulence are associated with certain clinical outcomes.

Copyright information:

© 2012 Mosby, Inc.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Creative Commons License

Export to EndNote